C

Changchun BCHT Biotechnology Co
SSE:688276

Watchlist Manager
Changchun BCHT Biotechnology Co
SSE:688276
Watchlist
Price: 19.44 CNY 3.08%
Market Cap: 8B CNY

Changchun BCHT Biotechnology Co
Investor Relations

Changchun BCHT Biotechnology Co. engages in the research and development, production and sale of human vaccines. The company is headquartered in Changchun, Jilin and currently employs 1,252 full-time employees. The company went IPO on 2021-06-25. The firm is mainly engaged in the research and development, production and sales of human vaccines. The firm has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The firm also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The firm mainly conducts business within the domestic market.

Show more
Loading
688276
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Wei Kong
GM & Director
No Bio Available
Mr. Zhaofeng Meng
Chief Financial Officer
No Bio Available
Mr. Chunlai Jiang
Executive Deputy GM & Director
No Bio Available
Mr. Zhe Zhang
Board Secretary
No Bio Available
Mr. Xiaohui Chen
Chief Operating Specialist
No Bio Available
Ms. Wei Wei
Deputy General Manager
No Bio Available
Mr. Changlin Zhu
Core Technical Staff
No Bio Available

Contacts

Address
JILIN
Changchun
No. 138, Zhuoyue Street, Chaoyang District
Contacts
+8643181871543
www.bchtpharm.com